Note the interesting fact that the last sentence doesn't really gibe with the earlier paragraphs. And note that AE table doesn't include the LFT excursions.
b) And the key to understanding this is that the protocol diagram in the paper implies they started Roxa and then split into the various iron groups. I.e. randomization probably happened after start of Roxa.
1) there is an apparent pattern of obfuscation (e.g. not in the table numbers, only in the text in multiple papers) on liver issues (the great thing about putting this stuff out there is it makes me put the pieces together in different ways)
2) all the significant issues crop up very early in the trial (e.g. both of the above events were very early, and, as I noted in my post yesterday, the CV issues also appear very early.) It looks like a giant bodywide remodelling.
3) 041, which I suspect was a later trial (e.g. last published), explicitly excludes anyone who has more than 3 drinks a day. 041 also avoided the withdrawls for liver issues.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.